iPro2 Professional CGM with Enlite Provides Critical Link Between Glucose Variability and Lifestyle for Improved Diabetes Control DUBLIN - Sept. 1, 2016 - Medtronic plc (MDT), the global leader in ...
Medtronic, Inc. (NYSE: MDT) today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in adults with diabetes of its Enlite™ Sensor, the ...
Medtronic plc (NYSE:MDT) recently announced the receipt of the U.S. FDA approval for its Enlite sensor, which is to be used with the iPro2 Professional Continuous Glucose Monitoring (CGM) system. This ...
MiniMed® 530G with Enlite Automatically Stops Insulin Delivery If Sensor Glucose Levels Fall Below a Predetermined Threshold MINNEAPOLIS - September 27, 2013 -Medtronic, Inc. (NYSE:MDT) today ...
With a great deal of hype, and a few delays from the US Food and Drug Administration (FDA), Medtronic in September 2013 released its newest combined pump and continuous glucose monitor (CGM), the ...
Latest Continuous Glucose Monitoring Sensor Provides Improved Comfort and Sensing Experience VIENNA - February 6, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the European launch of new ...
With MiniMed 530G, Medtronic Seeks New CMS Code PLAINSBORO, N.J. — With its unveiling of the first FDA-approved system that includes the name “artificial pancreas,” Medtronic Diabetes has applied for ...
Medtronic plc (NYSE: MDT) disclosed that the FDA has given its approval of the Enlite sensor for use with iPro2 Professional Continuous Glucose Monitoring (CGM) system. This is a market-leading CGM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback